Skip to main content

Table 3 Escalation, de-escalation, elimination and stopping boundaries for each level depending on the number of patients with DLT

From: Tolerability of concurrent external beam radiotherapy and [177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)

Action

The number of patients treated at each dose

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

Level 1:

 Stop the trial if # of DLT >  = 

NA

NA

2

3

3

4

4

4

5

5

6

6

6

7

7

7

8

8

Level 2 and 3:

 Escalate if # of DLT <  = 

0

0

0

0

1

1

1

1

2

2

2

2

3

3

3

3

4

4

 De-escalate if # of DLT >  = 

1

1

2

2

2

3

3

3

4

4

4

5

5

6

6

6

7

7

 Eliminate dose if # of DLT >  = 

NA

NA

3

4

5

5

6

6

7

7

7

8

8

9

9

10

10

11

  1. DLT Dose limiting toxicity, NA Not applicable, # number